Calcium Channel Blocker Therapy: When a Drug Works, it Works. When it Doesn't, it Doesn't
نویسندگان
چکیده
منابع مشابه
Pair Programming: When and Why it Works
1 Stanford University, Department of Management Science and Engineering, Terman Engineering Center, 3rd Floor, Stanford CA 94305 [email protected] 2 Stanford University, Department of Computer Science, 353 Serra Mall, Stanford CA 94305 {plummer, srk}@cs.stanford.edu 3 Stanford University, Department of Mechanical Engineering, Building 530, 440 Escondido Mall, Stanford CA 94305 ozgur@stanfo...
متن کاملWhen expert advice works, and when it does not
0th experts and users of expertise fail to grasp the role. of expertise in decision making. Of course, expert advice is essential in complex human activities, but those who follow that advice also sometimes regret it. Under what conditions does expert advice and action tend to produce satisfactory outcomes? Recent studies of technological controversies and governmental regulatory procedures rev...
متن کاملSkin blood flow in adult human thermoregulation: how it works, when it does not, and why.
The thermoregulatory control of human skin blood flow is vital to the maintenance of normal body temperatures during challenges to thermal homeostasis. Sympathetic neural control of skin blood flow includes the noradrenergic vasoconstrictor system and a sympathetic active vasodilator system, the latter of which is responsible for 80% to 90% of the substantial cutaneous vasodilation that occurs ...
متن کاملHow It Works and Why It Matters
This paper provides simulation practitioners and consumers with a grounding in how discrete-event simulation software works. Topics include discrete-event systems; entities, resources, control elements and operations; simulation runs; entity states; entity lists; and entity-list management. The implementation of these generic ideas in AutoMod, SLX, and Extend is described. The paper concludes w...
متن کاملHow it acts, how it works
Interferon beta (IFNβ) and glatiramer acetate (GA) were the first immunomodulators approved to the treatment of relapsing-remitting multiple sclerosis (MS) and clinically isolated syndromes. Despite the enlargement of the therapeutic armamentarium, IFNβ and GA remain the most widely drugs and the therapeutic mainstay of MS. Objective: To review the mechanisms of action of IFNβ and GA and main c...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Advances in Pulmonary Hypertension
سال: 2017
ISSN: 1933-088X
DOI: 10.21693/1933-088x-15.4.184